ICU Medical (IC7) Stock Statistics & Valuation Metrics

ICU Medical has a market cap or net worth of CHF3.40B. The enterprise value is CHF4.31K.

ICU Medical has ― shares outstanding. The number of shares has decreased by -2.65% in one year.

ICU Medical’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.69%.

The current PE Ratio of ICU Medical is 90.1. ICU Medical’s PEG ratio is -47.74.

In the last 12 months, ICU Medical had revenue of 2.23B and earned 732.00K in profits. Earnings per share was 0.03.

In the last 12 months, operating cash flow was 167.43M and capital expenditures -87.03M, giving a free cash flow of 80.40M billion.

ICU Medical pays an annual dividend of ―, resulting in a dividend yield of ―

ICU Medical upcoming earnings date is Aug 6, 2026, After Close (Confirmed).

ICU Medical as a current ratio of 2.36, with Debt / Equity ratio of 63.51%

In the past 12 months, ICU Medical has paid 2.44M in taxes.

ICU Medical EV to EBITDA ratio is 14.09, with an EV/FCF ratio of 50.10.

ICU Medical has CHF288.33M in cash and marketable securities with CHF1.34B in debt, giving a net cash position of -CHF1.05B billion.

Gross margin is 36.36%, with operating margin of 4.80%, and net profit margin of 0.03%.

The average price target for ICU Medical is CHF137.03, which is 11.43% higher than the current price. The consensus rating is Strong Buy